WHITNEY GORE: Open Payments
NPI 1669084091 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 80 payments from 25 companies in 2025. Trend: 2023 $937 · 2024 $1,719 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $251 |
| PFIZER INC. | 12 | $220 |
| Novo Nordisk Inc | 11 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| Antares Pharma, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Amgen Inc. | 3 | $53 |
| Exact Sciences Corporation | 3 | $49 |
Products named: NURTEC ODT, VRAYLAR, Kerendia, Ozempic, REXULTI, TRELEGY ELLIPTA, XYOSTED, Rybelsus.
Industry payments across AL — which companies pay providers there.
